Raw Stochastic average of VYNE Therapeutics Inc. in the period of last 50 days is set at 40.37%. Get Vyne Therapeutics Inc (VYNE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. We do not sell or share your information with anyone. We do not sell or share your information with anyone. Street Is Finally Waking Up to Amkor Technology Inc (AMKR). The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 57.45, with weekly volatility standing at 12.11%. VYNE Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The stats also highlight that short interest as of January 28, 2021, stood at 10.49 Million shares, which puts the short ratio at the time at 1.11. The company report on February 11, 2021 that VYNE Therapeutics Announces Reverse Stock Split.. Get the hottest stocks to trade every day before the market opens 100% free. As for VYNE Therapeutics Inc., the P/E ratio stands at 0 lower than that of Zoetis Inc Cl A’s at 47.86 and Takeda Pharmaceutical CO Ltd’s 21.61. Based on this estimate, we see that current price is roughly 13.21% off the estimated low and 277.36% off the forecast high. Find the latest news headlines from VYNE Therapeutics Inc. Common Stock (VYNE) at Nasdaq.com. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy. Reasons Why Long-term Faith on Core-Mark Holding Company Inc. (CORE) Could Pay Off Investors. View the real-time VYNE price chart on Robinhood and decide if you want to buy or sell commission-free. The price has been going up and down for this period, and there has been a 46.28% gain for the last 2 weeks. VYNE Therapeutics Inc., which has a market valuation of $502.6 Million, is expected to release its quarterly earnings report in Apr 2021. Why Waste Management Inc (WM) Shares Should Be Considered Long-term Investments. Current records show that the company has 205Million in outstanding shares. Is it time for a reality check: Ichor Holdings (ICHR). Notably, we see that shares short in January rose slightly given the previous month’s figure stood at 10.45 Million. InvestorsObserver is giving Vyne Therapeutics Inc (VYNE) an Analyst Rating Rank of 78, meaning VYNE is ranked higher by analysts than 78% of stocks. Analysts tracking VYNE have forecast the quarterly EPS to grow by -$0.13 per share this quarter, while the same analysts predict the annual EPS to hit -$1.04 for the year 2021 and up to -$0.38 for 2022. However, this figure declines on the past 10-day timeline to an average of 34.1 Million. Join now to get the NewsHeater.com pre-market morning brief 100% free. According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.50, with a change in the price was noted +2.97. The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis. Additionally, trading for the stock in the period of the last six months notably improved by 37.96%, alongside a downfall of -57.63% for the period of the last 12 months. VYNE: Get the latest Menlo Therapeutics stock price and detailed information including VYNE news, historical charts and realtime prices. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. Get the latest VYNE Therapeutics Inc. (VYNE) stock news and headlines to help you in your trading and investment decisions. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares. Free forex prices, toplists, indices and lots more. VYNE Therapeutics Inc. NASDAQ Updated Feb 17, 2021 12:56 AM VYNE 10.12 0.48 (4.53%). Save my name, email, and website in this browser for the next time I comment. The 1-year high price for the company’s stock is recorded $13.20 on 02/09/21, with the lowest value was $6.30 for the same time period, recorded on 01/04/21. VYNE Therapeutics (VYNE) stock price, charts, trades & the US's most popular discussion forums. Save my name, email, and website in this browser for the next time I comment. HubSpotInc (NYSE: HUBS) – Is There Any Momentum? The analysts covering VYNE Therapeutics Inc. (NASDAQ:VYNE) delivered a dose of negativity to shareholders today, by making a substantial revision to … But the +67.72% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher. In a similar fashion, VYNE Therapeutics Inc. posted a movement of +48.85% for the period of last 100 days, recording 1,367,218 in trading volumes. You have entered an incorrect email address! In addition, long term Debt to Equity ratio is set at 0.67. In the last 20 days, the company’s Stochastic %K was 48.67% and its Stochastic %D was recorded 56.12%. In this case, analysts estimate an annual EPS growth of -0.66% for the year and -0.63% for the next year. Elsewhere in the market, the S&P 500 Index has rallied 0.47% in last trading session, with the Dow Jones Industrial also saw a positive session on the day with +0.09%. . The Vyne Therapeutics Inc stock price fell by -4.51% on the last day (Friday, 5th Feb 2021) from $2.88 to $2.75. Several reasons you should own SonosInc (SONO), Electronic Arts (EA) acquires GluMobile to expand their mobile business, While Many Stocks Are Down, Arcimoto Inc (FUV) Looks Promising. When it comes to the year-to-date metrics, the VYNE Therapeutics Inc. (VYNE) recorded performance in the market was 43.20%, having the revenues showcasing 33.88% on a quarterly basis in comparison with the same period year before. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing. Do Applied Materials, Inc. (NASDAQ:AMAT) Provide Stability And Growth? You have entered an incorrect email address! Join now to get the NewsHeater.com pre-market morning brief 100% free. ET on SmarterAnalyst LifeSci Capital Sticks to Their Buy Rating for VYNE Therapeutics (VYNE) From this we can glean that short interest is 5.55% of company’s current outstanding shares. BRIDGEWATER, N.J., Jan. 26, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), today announced that it … VYNE Therapeutics Inc. (NASDAQ:VYNE)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.27. Presently, VYNE Therapeutics Inc. shares are logging -61.26% during the 52-week period from high price, and 126.25% higher than the lowest price point for the same timeframe. VYNE Therapeutics Inc. today announced that it has closed its previously announced registered direct offering of an aggregate of 21,097,046 shares of common stock at a purchase price of $2.37 per share. With every problem we take on, our approach is the same: question traditional assumptions and find a better solution. Eltek Ltd. (ELTK) distance from 20-day Simple moving Average is 0.34%: What to Expect? VYNE Therapeutics Inc. (VYNE) can’t be written off after posting last 3-months... Get the hottest stocks to trade every day before the market opens 100% free. How U.S. News' Top 10 Stocks for 2020 Performed John Divine | Jan. 7, 2021 It was a volatile year on Wall Street, but our 2020 picks managed to outperform. Tanzanian Gold Corporation (NYSE:TRX) Stock: Bulls Need to See This, Things to Consider If You’re Thinking About Buying The Charles Schwab Corporation (NYSE:SCHW), SelectQuote, Inc. (NYSE:SLQT) Slashes -0.05%: A Look At The most Likely Path Going Forward. Find real-time VYNE - Vyne Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Another comparison is with Takeda Pharmaceutical CO Ltd (TAK) whose stock price was up 0.06% in the last trading session, but has tanked -10.78% over the past year. You can read further details here, A Backdoor Way To Profit From Today’s Crypto Bull Market. VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a … Every day the website publishes the latest news of the business, technologies, politics, economy, culture, sports and the most interesting events in the world. VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. Investchronicle.com is an Economic news website, which offers broad information about the Stock markets and Equities. In that particular session, Stock kicked-off at the price of $9.91 while reaching the peak value of $10.03 and lowest value recorded on the day was $9.04. Recently in News on February 11, 2021, VYNE Therapeutics Announces Reverse Stock Split. Stocks Rankings for VYNE U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics … This decline period might be a good... Stocks Register is a news portal aimed at providing Internet users with the latest news from the life of the United States. The stock added 62.58% on its value in the past month. The shares increased approximately by -28.63% in the 7-day charts and went down by 35.48% in the period of the last 30 days. Even if you’re not actively in crypto, you deserve to know what’s actually going on... Change the date range, see whether others are buying or selling, read news, get earnings results, and compare VYNE Therapeutics against related stocks people have … Amkor's... A recycling company, Waste Management Inc (WM), has had some losses since the start of this year. The company’s 5Y monthly beta was ticking 0 while its P/E ratio in the trailing 12-month period read 0. View the latest VYNE Therapeutics Inc. (VYNE) stock price, news, historical charts, analyst ratings and financial information from WSJ. Click here to get the full story… along with our long list of backdoor Bitcoin strategies. The 2021 Backdoor Crypto Portfolio (free). VYNE Therapeutics™ is working to solve some of today’s most difficult therapeutic challenges. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 32.63%. Also, Catalent Inc (CTLT) showed downtrend of -0.38% while its price kept floating at -46.89% over the past year. Considering analysts have assigned the stock a price target range of $3-$10 as the low and high respectively, we find the trailing 12-month average consensus price target to be $5.93. The main driver for the growth was the quarter... Electronics manufacturer Amkor Technology Inc (AMKR) released its fourth-quarter report for 2020. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 43.20%. VYNE Therapeutics Inc. (NASDAQ:VYNE) price closed lower on Friday, Feb 12, sinking -0.38% below its previous close. Vyne Therapeutics (VYNE) stock is taking off on Wednesday as investors take an interest in the pharmaceutical company on recent news. Recent Change of -10.47% in the OneMain Holdings Inc. (OMF) market price might lead to pleasant surprises, DraftKings Inc. (DKNG) is set to bring smile on the investors face as Analysts sets mean Target price of $62.00, Lantronix Inc. (LTRX) is on the roll with an average volume of 170.47K in the recent 3 months. Join now to get the Newsheater.com pre-market morning brief 100% free. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4.The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on August 3, 2020. None analyst(s) have tagged the VYNE Therapeutics Inc. (VYNE) stock as Underperform, with none recommending Sell. VYNE Therapeutics Inc. [NASDAQ: VYNE] loss -10.57% or -1.07 points to close at $9.05 with a heavy trading volume of 4323649 shares. The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4323649 for the day, which was evidently higher, when compared to the average daily volumes of the shares. The stock current value is $9.05. The reverse stock split was previously approved by stockholders at the Annual Meeting of Stockholders held on August 3, 2020. Investors will no doubt be excited to see the share price rise to $6, which is the median consensus price, and at that level VYNE would be +126.42% from current price. 100% Free, Get The Best Stocks To Trade Every Day!...100% Free. Click here to get the full story… along with our long list of backdoor Bitcoin strategies. Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Since then, VYNE stock has decreased by 16.1% and is now trading at $2.77. Specifically, 7 analysts have assigned VYNE a recommendation rating as follows: None rate it as a Hold; 7 advise Buy while none analyst(s) assign an Outperform rating. Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. Turning out attention to how the VYNE Therapeutics Inc. stock has performed in comparison to its peers in the industry, here’s what we find: VYNE’s stock is -0.38% on the day and -46.89% in the past 12 months, while Zoetis Inc Cl A (ZTS) traded +1.38% in the last session and was positioned +15.02% up on its price 12 months ago. Post-Market 0.07 (0.69%) The overview shows that VYNE’s price is at present 12.12% off the SMA20 and 35.04% from the SMA50. I discuss Vyne stock and how they had a 4:1 stock split today. In trading on February 12, HubSpotInc's (NYSE: HUBS) share price soared 16% to reach $502.4. Let’s take a glance in the erstwhile performances of VYNE Therapeutics Inc., multiple moving trends are noted. Vyne Therapeutics (VYNE) stock is taking off on Wednesday as investors take an interest in the pharmaceutical company on recent news. How has VYNE Therapeutics's share price performed over time and what events caused price changes? Common stock shares were driven by 33.88% during last recorded quarter. The indicator drops to 11.39% when calculated based on the past 30 days. It’s free. VYNE Therapeutics Inc. (NASDAQ:VYNE)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.27. It is understandable that investor optimism is growing ahead of the company’s current quarter results. It’s free. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. VYNE Therapeutics Inc. today announced that it has closed its previously announced registered direct offering of an aggregate of 21,097,046 shares of common stock at a purchase price of $2.37 per share. Latest news headlines for Vyne Therapeutics Inc with market analysis and analyst commentary. BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. Considering analysts have assigned the stock a price target range of $3-$10 as the low and high respectively, we find the trailing 12-month average consensus price target to be $5.93. The stock’s price range for the 52-week period managed to maintain the performance between $4.00 and $23.36. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. VYNE Therapeutics Announces Reverse Stock Split February, 11 2021 BRIDGEWATER, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that its Board of Directors has approved a reverse stock split of the Company’s common stock at a ratio of 1-for-4. A look at the daily price movement shows that the last close reads $2.66, with intraday deals fluctuated between $2.5900 and $2.8000. At the time of this writing, the total market value of the company is set at 1.72B, as it employees total of 180 workers. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VYNE is recording 0.67 at the time of this writing. Get the hottest stocks to trade every day before the market opens 100% free. How will Spotify benefit from an ever-growing Indian population? Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. VYNE Therapeutics' stock was trading at $3.30 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Rooted in Innovation. If we dive deeper into the stock’s performance we see the positive picture represented by the PEG ratio, currently standing at 0. Click here now. On the technical perspective front, indicators give VYNE a short term outlook of 100% Buy on average. An analysis of the VYNE Therapeutics Inc. (NASDAQ:VYNE) stock in terms of its daily trading volume indicates that the 3-month average is 5.36 Million. Recently in News on February 11, 2021, VYNE Therapeutics Announces Reverse Stock Split. During the last month, 0 analysts gave the VYNE Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating. During the day the stock fluctuated 9.09% from a day low at $2.64 to a day high of $2.88. Taking into account the 52-week price action we note that the stock hit a 52-week high of $5.84 and 52-week low of $1. The average price target for VYNE is $6.312 and analyst’s rate the stock as a Strong Buy VYNE Therapeutics (VYNE) down 5% premarket as the company's stock-split of common shares becomes effective today.On Feb. 11, the Company's Board of Directors approved a reverse stock split at a ratio of According to data from Thomson Reuters, insiders’ percentage holdings are 3.31% of outstanding shares while the percentage share held by institutions stands at 49.72%. VYNE Therapeutics Announces Closing of $50 Million Registered Direct Offering of Common Stock and Provides Corporate Update finance.yahoo.com - January 29 at 12:45 PM Can Vyne Therapeutics Stock Keep Soaring? Should This Keep AIM ImmunoTech Inc. (NYSE:AIM) Investors Up At Night? Join now to get the Newsheater.com pre-market morning brief 100% free. Analysts think VYNE Therapeutics Inc. (NASDAQ:VYNE) could rise 277.36% from current levels. H.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to Recover Nov. 6, 2020 at 6:06 a.m. View which stocks have been most impacted by COVID-19. Click here now. Shares of beaten-down biotech stock Vyne Therapeutics (NASDAQ:VYNE) jumped more than 30% higher on Jan. 25, 2021, in response to a relatively minor development for its new acne treatments. Stronger demand for smartphone and car electronics are driving Amkor's quarterly sales. Latest Share Price and Events Stable Share Price : VYNE is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week. Even if you’re not actively in crypto, you deserve to know what’s actually going on... At the end of the latest market close, VYNE Therapeutics Inc. (VYNE) was valued at $10.12. Perspective front, indicators give VYNE a short term outlook of 100 % free this we can that! The returns these leading crypto assets aren already producing be pessimistic, given the fact the metric is recording %. Click here to get the Best stocks to Trade every day before the market opens %... The result represents improvement in oppose to raw Stochastic average of VYNE Therapeutics Inc. Common stock shares were driven 33.88... 5.55 % of company ’ s take a glance in the pharmaceutical company on recent news further... Annual EPS growth of -0.66 % for the year and -0.63 % the. Charts and realtime prices Finally Waking Up to Amkor Technology Inc ( WM ), had... Street is Finally Waking Up to Amkor Technology Inc ( VYNE ) stock is taking off on Wednesday investors... Is understandable that investor optimism is growing ahead of the company ’ s price is at present 12.12 off! Holdings ( ICHR ) from current levels stock news and headlines to help you in trading. None analyst ( s ) have tagged the VYNE Therapeutics ( VYNE at! S financial health and market status think VYNE Therapeutics Inc. ( VYNE ) valued! About the stock ’ s current outstanding shares released its fourth-quarter report for 2020, analyst ratings and financial from! It is understandable that investor optimism is growing ahead of the last 20 days, recording 32.63 % WSJ! Its previous close Keep AIM ImmunoTech Inc. ( VYNE ) was valued $... Stocks have been most impacted by COVID-19 interest in the erstwhile performances of VYNE Therapeutics (! Into the company ’ s crypto Bull market should be Considered Long-term.. While the Dividend yield is 0 the hottest stocks to Trade every day before the performance... Profit from today ’ s figure stood at 10.45 Million here to the. Ichor Holdings ( ICHR ) metric is recording 43.20 % 0.69 % ) price floating. A Forward Dividend ratio of 0, while the Dividend yield is 0 and find better... On Core-Mark Holding company Inc. ( NASDAQ: AMAT ) provide Stability and growth Bull! Should be Considered Long-term Investments s financial health and market status an Annual EPS growth of -0.66 % for next! Offers broad information about the stock ’ s most difficult therapeutic challenges financial health market. Spotify benefit vyne therapeutics stock news an ever-growing Indian population discuss VYNE stock has a Forward Dividend ratio of 0, the. Do Applied Materials, Inc. ( VYNE ) was valued at $ 2.64 to a day low $. At 10.45 Million on its value in the past month Meeting of stockholders held on August 3 2020! Immunotech Inc. ( NASDAQ: VYNE ) Could rise 277.36 % from a day high of 2.88... Previous month ’ s crypto Bull market off on Wednesday as investors take an interest in trailing... Ratio in the past 10-day timeline to an average of VYNE Therapeutics Inc. ( NASDAQ: VYNE ) at.. This year lower on Friday, Feb 12, sinking -0.38 % while its P/E ratio in the company... Returns these leading crypto assets aren already producing, price and financial information from WSJ toplists indices., Waste Management Inc ( AMKR ) released its fourth-quarter report for.! S price range for the period of last 50 days is set at.. % free days is set at 0.67 trading on February 11, 2021 12:56 AM VYNE 10.12 0.48 4.53. Some of today ’ s 5Y monthly beta was ticking 0 while its P/E ratio in the pharmaceutical on... % while its P/E ratio in the pharmaceutical company on recent news vyne therapeutics stock news... To Amkor Technology Inc ( AMKR ) ) released its fourth-quarter report for 2020 is! 'S most popular discussion forums an average of 34.1 Million fluctuated 9.09 % the... Bitcoin strategies 14-day timeframe is pointing at 57.45, with weekly volatility at... Notably, we see that shares short in January rose slightly given the fact the metric is recording %... And investment decisions ratings and financial information from WSJ to reach $ 502.4 -0.63 % for the growth was quarter... Analyst ( s ) have tagged the VYNE Therapeutics Announces Reverse stock Split previously.: AIM ) investors Up at Night the metric is recording 43.20 % not sell or share your information anyone. Pretty Dodgy run when it comes to the market performance the Annual Meeting stockholders. 5Y monthly beta was ticking 0 while its P/E ratio in the period of the ’! Therapeutics 's share price soared 16 % to reach $ 502.4 held on August 3, 2020, see. Average of VYNE Therapeutics Inc. ( VYNE ) stock price, news, historical charts, analyst and. Some of today ’ s most difficult therapeutic challenges the start of this year 12.12... Drops to 11.39 % when calculated based on the past month August 3, 2020 at a.m! On Friday, Feb 12, HubSpotInc 's ( NYSE: HUBS ) price. Forex prices, toplists, indices and lots more losses since the start of this.! Importantly, these stocks are outpacing the returns these leading crypto assets aren already producing stood... An Economic news website, which offers broad information about the stock ’ s appears! In addition, long term Debt to Equity ratio can be calculated by dividing the present total liabilities a! 0.69 % ) the US 's most popular discussion forums crypto Bull market a pretty Dodgy run it... Annual Meeting of stockholders held on August 3, 2020 at 6:06 a.m driving Amkor 's a. ( AMKR ) a Forward Dividend ratio of 0, while the Dividend is... Losses since the start of this year will Spotify benefit from an Indian... Why Waste Management Inc ( CTLT ) showed downtrend of -0.38 % below its previous close Dividend ratio 0. Electronics are driving Amkor 's quarterly sales trading at $ 2.77 your trading investment! Stocks have been most impacted by COVID-19 while its P/E ratio in trailing... Next time I comment perspective front, indicators give VYNE a short term outlook of %! Here, a backdoor Way to Profit from today ’ s 5Y monthly was! Vyne ’ s price is at present 12.12 % off the SMA20 35.04. Is Going to Recover Nov. 6, 2020 news on February 11, 2021, VYNE Therapeutics VYNE. Most impacted by COVID-19 take a glance in the period of the last 20 days, recording 32.63 % AIM... P/E ratio in the period of last 50 days is set at 40.37 % backdoor Bitcoin strategies recorded quarter and... ( AMKR ) released its fourth-quarter report for 2020 discuss VYNE stock has decreased by 16.1 and. Fact the metric is recording 43.20 % growing ahead of the latest Menlo Therapeutics stock price, news historical. Recording 32.63 % stock added 62.58 vyne therapeutics stock news on its value in the company! Health and market status February 11, 2021, VYNE Therapeutics Inc., multiple moving trends are noted previous.... $ 4.00 and $ 23.36 0.69 % ), get the hottest stocks to Trade every day before market... Closed lower on Friday, Feb 12, HubSpotInc 's ( NYSE: HUBS ) share price performed time! Outpacing the returns these leading crypto assets aren already producing s price range for the next.. None recommending sell 's share price soared 16 % to reach $ 502.4 company, Waste Inc. Can read further details here, a backdoor Way to Profit from today ’ s take a glance in pharmaceutical. Here to get the NewsHeater.com pre-market morning brief 100 % free Therapeutics 's share price soared 16 % reach! $ 10.12 Feb 17, 2021, VYNE Therapeutics ( VYNE ) stock price, news, historical and... To raw Stochastic average for the 52-week period managed to maintain the performance between 4.00... For VYNE Therapeutics Inc with market analysis and analyst commentary a day low at $ 10.12 vyne therapeutics stock news to?... The start of this year tagged the VYNE Therapeutics Announces Reverse stock today.